Navigation Links
ConvaTec Names Nigel Clerkin Chief Financial Officer
Date:7/22/2014

LUXEMBOURG, July 22, 2014 /PRNewswire/ -- ConvaTec, a privately-held medical products and technologies company, today announced that Nigel Clerkin has been appointed chief financial officer of the company, effective July 22, 2014.

Mr. Clerkin was previously executive vice president and chief financial officer of Elan Corporation, a Dublin-based biotechnology company.  Mr. Clerkin was part of a senior team that helped build significant shareholder value at Elan, culminating in its sale to Perrigo, a pharmaceutical manufacturer, in December 2013.

"I am very pleased to welcome Nigel to ConvaTec," said Ken Berger, CEO of ConvaTec. "His track record in creating value at a major public company will be a great asset for us as we grow and evolve as a company."

"ConvaTec has outstanding products, a great reputation and a proven business platform that is primed to take advantage of emerging healthcare trends," said Mr. Clerkin.  "I am delighted to join ConvaTec at a very exciting time for the company."

Mr. Clerkin joined Elan in 1998 and held a series of roles in strategic planning and finance prior to being named CFO in 2011.  Earlier, Mr. Clerkin was an auditor with KPMG.  He holds bachelor's and master's degrees in accounting from Queens University, Belfast, and is a fellow of Chartered Accountants Ireland.

Mr. Clerkin succeeds John Cannon, who will remain at ConvaTec as senior vice president, financial operations.

About ConvaTec
ConvaTec is a global medical products and technologies company, with leading market positions in wound therapeutics, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. ConvaTec has over 8,000 employees, with 11 manufacturing sites in 8 countries, and we do business in more than 100 countries. We are owned by Nordic Capital and Avista Capital Partners. More information is available at www.convatec.com.

Contacts

Media:
Punnie Donohue
ConvaTec
1-908-904-2151
punnie.donohue@convatec.com

Investors:
Bob McKee
ConvaTec
1-336-547-3701
bob.mckee@convatec.com


'/>"/>
SOURCE ConvaTec
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. ConvaTec Announces 2013 Third Quarter Earnings Call
2. ConvaTec Announces 2013 Second Quarter Earnings Call
3. ConvaTec Announces 2013 First Quarter Earnings Call
4. ConvaTec Announces 2012 Year-End Earnings Call
5. ConvaTec, A Leader In Antimicrobial Dressings And Infection Management, To Host Live International Webcast On Minimizing Risk Of Wound Infections
6. ConvaTec To Acquire Intermittent Catheter Provider
7. ConvaTec Introduces Enhanced Flexi-Seal® SIGNAL® FMS
8. ConvaTec Announces Acquisition of AbViser Medical, LLC
9. ConvaTec Donates $10,000 To AAWC Global Volunteers Program Through SAWC Walk For Wellness
10. Aptuit Names Dr. Paul Overton Executive VP, Business Development & Marketing; Enhances Sterile Drug Product Capabilities
11. Express Scripts Names Cathy R. Smith Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
Breaking Medicine News(10 mins):